Blog

The Woodruff Lab contributes to the Women’s Health Research Institute and Oncofertility Consortium blogs. Read the latest information disseminated from these blogs below:  

Understanding the Science of Acupuncture

Acupuncture is a traditional medicine that’s been practiced in China and other Asian countries for thousands of years. Its proponents say it can do everything from relieving pain to bringing a general sense of wellness. Others think the only benefits you get from acupuncture are in your head. Recent studies have found that both sides may have a point. Acupuncture can be effective for certain health problems, such as some types of chronic pain. But how it works is something of a mystery.

Women Benefit More than Men with New Heart Device

Research has shown that women are not treated as aggressively as men after a heart attack or stroke.   A new study has found that women benefit more than men from a device that improves the heart’s pumping ability and corrects abnormal heart rhythms.  The new device combines cardiac resynchronization therapy with an implanted defibrillator.  The study published in the Journal of the American College of Cardiology found that the device was linked to a 70% reduction in heart failure in women vs.

Drinking Raw Milk May Not Be a Healthy Idea

As more people turn to organic lifestyles, we thought it would be a good idea to share this post on raw milk.
Posted February 15, 2011     By LCDR Casey Barton Behravesh, DVM, DrPH, US Public Health Service

There are many reasons why some people are thinking about drinking raw milk these days. (Raw milk is milk that has not been pasteurized to kill harmful germs.) Some people want to eat less processed food. Others have heard that raw milk contains more of certain nutrients than pasteurized milk, or that it can prevent or even solve various health problems. Still others think of buying raw milk as one way to support local farmers and sustainable agriculture.

3-D Mammography System Approved

The U.S. Food and Drug Administration (FDA) has approved the first 3-D mammography imaging system that may boost accuracy in breast cancer detection and diagnosis.

A mammogram is a safe, low-dose X-ray of the breast that is the best tool for early detection of breast cancer. However, with the limitations of conventional two-dimensional (2-D) imaging, about 10 percent of women undergo additional testing after the initial screening exam for abnormalities that are later determined to be noncancerous.

Women Veterans Need Our Support!

Fatigues to Fabulous to Aid Women Veterans

The Society for Women’s Health Research (SWHR) announced today that Tuesday, February 15th during Mercedes Benz Fashion Week, SWHR and their partner Grace After Fire, a support network for women veterans, will be launching the Fatigues to Fabulous (F2F) campaign – a national program created to honor the service of women veterans and support their transition home. The campaign is working with the fashion industry to help women make the transition to a civilian wardrobe, raise awareness of the challenges women veterans face upon return, and harness resources to support them.

High School Girls Focus on Science

This weekend, the Oncofertility Consortium, along with the Institute for Women’s Health Research, is hosting the fifth annual Oncofertility Saturday Academy (OSA) at the Feinberg School of Medicine at Northwestern University.  OSA is an informal science education program designed to expose high school girls to the wonders of science and medicine through hands-on and experiential activities.  These high school girls come from the Young Women’s Leadership Charter School, on the near sou

Drug to Reduce Preterm Birth in At-Risk Pregnant Women Approved

The U.S. Food and Drug Administration on Feb. 4, 2011, approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth. The drug is not intended for use in women with a multiple pregnancy, such as a twin pregnancy, or other risk factors for preterm birth.

The FDA approved Makena under the agency’s accelerated approval regulations that allow promising drugs to be approved based on a surrogate endpoint benefit (here, reducing the risk of delivery before 37 weeks of pregnancy) that is reasonably likely to predict a clinical benefit.